Where the concern came from
A 2009 placebo-controlled crossover study involved 20 college-aged rugby players and a three-week supplementation period. It measured testosterone and dihydrotestosterone, usually called DHT. The abstract reported an increase in DHT and in its ratio to testosterone under the studied protocol.
That study did not directly measure hair loss. A hormone measurement can raise a research question, but it is not the same outcome as a count of hairs, a change in density or a clinical diagnosis of alopecia. Describing the trial as proof that creatine made participants lose their hair would replace the measured endpoint with one it did not assess.
The protocol also included a loading phase and differed from many everyday routines. We are not reproducing it as a recommended schedule. The distinction between a research protocol and personal use is also central to our timing and rest-day guide.
A newer trial measured hair directly
A 2025 randomized trial recruited 45 resistance-trained men aged 18–40; 38 completed the study. It compared creatine monohydrate with placebo for 12 weeks and measured both hormones and hair-related outcomes using standardized assessment methods. That is a more direct way to examine the hair question than inferring it from a hormone alone.
The investigators reported no significant group-by-time differences in the measured hormones or hair outcomes. The findings argue against the claim that the studied creatine protocol caused the measured hair changes during that period in those participants. They should not be turned into a promise that no individual could ever experience hair loss while using creatine.
Duration and population remain part of the result. Twelve weeks in trained men aged 18–40 is not a multi-year study in women, older adults or every group with existing hair conditions. Nor did the trial compare the finished retail powders reviewed on this site. Ingredient evidence does not identify a brand winner.
Funding and author interests remain relevant
The paper’s funding statement reports no funding associated with the work. Its disclosures nevertheless identify supplement-industry advisory, research-support or consulting relationships for several authors. Those are separate facts; the absence of a study grant does not erase disclosed professional relationships.
Disclosures do not automatically invalidate the data. They help readers understand context and the value of independent replication. The same standard applies when a study’s findings are favorable to a product category and when they raise concerns. Our study desk uses people, findings and open questions as separate views for that reason.
A review should avoid selecting only the part of the evidence that supports its commercial position. The sponsored Strong Suit review remains a label and offer review, not a claim that this particular brand was proven unable to affect hair.
No detected difference is a bounded finding
When a trial reports no statistically significant difference, its size, measurement methods and follow-up still matter. It can provide useful evidence without proving that every possible effect is zero. Rare events, slow changes or responses in an unstudied group may require different research.
At the same time, uncertainty is not proof of harm. It would be misleading to use the mere possibility of an unmeasured effect as evidence that creatine causes baldness. A fair statement preserves both points: the newer direct trial did not find the proposed effect under its conditions, and those conditions do not cover every person or duration.
Readers over 50 should keep that age limit visible. Our creatine after 50 note discusses research designed around a different population and outcome. Evidence about strength in older adults cannot fill the hair trial’s age gap, just as the hair trial cannot establish strength benefits after 50.
Hair changes need their own assessment
The American Academy of Dermatology explains that hair loss has many possible causes, including hereditary patterns, illnesses, stress, medicines and hair-care practices. The fact that a change follows a new supplement does not establish that the supplement caused it. It also does not justify dismissing the change without asking what else may be happening.
If you notice persistent or concerning shedding, make a dated record of when it began and discuss it with an appropriate clinician or dermatologist. Include medicines and supplements, recent illness and other relevant changes. Do not stop a prescribed medicine or start a hair treatment solely because an online review proposes an explanation.
A useful product record contains the exact name, label, lot and when use began. It is more informative than saying only that you take a fitness supplement. A multi-ingredient pre-workout and a single-ingredient creatine powder may expose a person to different substances, even if both have creatine on the front.
Product format does not answer the hair question
Capsules, flavored powders and plain powders are not separate evidence categories for hair safety simply because their packaging differs. Check the active form and the rest of the ingredients. Our capsules versus powder note addresses convenience and label arithmetic without claiming one format protects hair better.
The Nutricost review and BulkSupplements review document current monohydrate labels. They do not turn the 2025 trial into testing of those actual containers. Certification and contaminant reports answer additional quality questions, not the clinical question of hair outcomes for each buyer.
The sentence to carry forward
The current direct trial did not find a difference in its measured hair outcomes over 12 weeks in the young men who completed it. The older hormone trial did not measure hair loss. Those two sentences describe the evidence more accurately than saying creatine certainly causes baldness or can never be related to anyone’s concern.
That level of precision leaves room for informed product discussion and for medical assessment when hair changes occur. It also keeps the decision separate from the publication’s sponsored placement. A supplement review should help clarify the evidence, not persuade a reader to ignore a symptom or buy reassurance in a jar.